Selectins in cancer immunity.
Selectins in cancer immunity.
复制标题
DOI:
10.1093/glycob/cwx105
复制
发表时间:
2018-09-01
期刊:
影响因子:
4.3
通讯作者:
Borsig L
中科院分区:
文献类型:
--
作者:
Borsig L
Selectins are vascular adhesion molecules that mediate physiological responses such as inflammation, immunity and hemostasis. During cancer progression selectins promote various steps enabling the interactions between tumor cells and the blood constituents, including platelets, endothelial cells, and leukocytes. Selectins are carbohydrate-binding molecules that bind to sialylated, fucosylated glycan structures. The increased selectin ligand expression on tumor cells correlates with enhanced metastasis and poor prognosis for cancer patients. While, many studies focused on the role of selectin as a mediator of tumor cell adhesion and extravasation during metastasis, there is evidence for selectins to activate signaling cascade that regulates immune responses within a tumor microenvironment. L-selectin binding induces activation of leukocytes, which can be further modulated by selectin-mediated interactions with platelets and endothelial cells. Selectin ligand on leukocytes, PSGL-1, triggers intracellular signaling in leukocytes that are induced through platelet’s P-selectin or endothelial E-selectin binding. In this review I summarize the evidence for selectin-induced immune modulation in cancer progression that represents a possible target for controlling tumor immunity.
登录
查看更多内容
影响因子:
7.3
作者:
Hobbs SJ;Nolz JC
通讯作者:
Nolz JC
影响因子:
6.2
作者:
St Hill CA;Krieser K;Farooqui M
通讯作者:
Farooqui M
DOI:
10.1073/pnas.93.26.15376
发表时间:
1996-12-24
影响因子:
11.1
作者:
Brenner, B;Gulbins, E;Lang, F
通讯作者:
Lang, F
DOI:
10.1056/nejmra1514296
发表时间:
2016-11-03
期刊:
The New England journal of medicine
影响因子:
--
作者:
Boussiotis VA
通讯作者:
Boussiotis VA
影响因子:
11.2
作者:
Häuselmann I;Roblek M;Protsyuk D;Huck V;Knopfova L;Grässle S;Bauer AT;Schneider SW;Borsig L
通讯作者:
Borsig L